Filing Details
- Accession Number:
- 0001437749-13-010884
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-14 19:27:12
- Reporting Period:
- 2013-08-14
- Filing Date:
- 2013-08-14
- Accepted Time:
- 2013-08-14 19:27:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1003642 | Impax Laboratories Inc | IPXL | Pharmaceutical Preparations (2834) | 650403311 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1245188 | L Robert Burr | C/O Impax Laboratories, Inc. 30831 Huntwood Avenue Hayward CA 94544 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-08-14 | 1,500 | $21.15 | 51,325 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,057 | Indirect | By Robert L. Burr IRA Account |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.